Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 2/20 | 0.59 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.54 |
| ▸ | IDO1 | P14902 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | HPGD | P15428 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30538128 | 1.00 | BACE1 (0.59) | BACE1TRPA1IDO1TDP1TP53 | |
| SCHEMBL14363399 | 0.91 | BACE1 (0.51) | BACE1TRPA1IDO1TDP1TP53 | |
| SCHEMBL6847806 | 0.88 | TRPA1 (0.56) | BACE1TRPA1IDO1TDP1TP53 | |
| SCHEMBL29941912 | 0.88 | TRPA1 (0.56) | BACE1TRPA1IDO1TDP1TP53 | |
| SCHEMBL14283893 | 0.87 | BACE1 (0.55) | BACE1TRPA1TDP1TP53ALOX15 | |
| SCHEMBL14363365 | 0.86 | TRPA1 (0.62) | BACE1TRPA1IDO1TDP1TP53 | |
| SCHEMBL31027246 | 0.86 | BACE1 (0.62) | BACE1TRPA1TDP1TP53ALOX15 | |
| SCHEMBL1163817 | 0.86 | BACE1 (0.56) | BACE1TRPA1TDP1TP53MCL1 | |
| SCHEMBL29615176 | 0.86 | BACE1 (0.56) | BACE1TRPA1TDP1TP53MCL1 | |
| SCHEMBL4280343 | 0.86 | BACE1 (0.62) | BACE1TRPA1TDP1TP53ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12503480-B2 | Cyclic phosphazene compound having oxaphosphorin ring-containing structure | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2025-12-23 | — | — | US | disclosed |
| US-20230339994-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2023-10-26 | — | — | US | disclosed |
| EP-4202013-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | Fushimi Pharmaceutical Co., Ltd. (JP) | 2023-06-28 | — | — | EP | disclosed |
| WO-2022019021-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | 株式会社伏見製薬所 | 2022-01-27 | — | — | WO | disclosed |
| EP-3924394-A1 | TRANSITION METAL BIS(PHENOLATE) COMPLEXES AND THEIR USE AS CATALYSTS FOR OLEFIN POLYMERIZATION | ExxonMobil Chemical Patents Inc. (US) | 2021-12-22 | — | — | EP | disclosed |
| WO-2020167821-A1 | TRANSITION METAL BIS(PHENOLATE) COMPLEXES AND THEIR USE AS CATALYSTS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-08-20 | — | — | WO | disclosed |
| US-20090011258-A1 | Method for Forming Paint Films and the Painted Objects | BASF COATINGS JAPAN LIMITED (JP) | 2009-01-08 | — | — | US | disclosed |
| WO-2006046117-A1 | WHITE BASECOAT COATING COMPOSITION, METHOD FOR FORMING COATING FILM AND COATED ARTICLE | BASF COATINGS JAPAN LTD. (DE) | 2006-05-04 | — | — | WO | disclosed |
| WO-2002018485-A1 | FLAME-RETARDED POLYPHENYLENE ETHER COMPOSITION AND METHOD OF MAKING SAME | GENERAL ELECTRIC COMPANY (US) | 2002-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339994-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | PFAS, PHOSPHO1, PAF1 | BACE1 1578/4885TRPA1 1153/4885IDO1 4378/4885 |
| US-12503480-B2 | Cyclic phosphazene compound having oxaphosphorin ring-containing structure | PFAS, PHOSPHO1, PAF1 | BACE1 1578/4885TRPA1 1153/4885IDO1 4378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.